328 related articles for article (PubMed ID: 10611317)
1. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
[TBL] [Abstract][Full Text] [Related]
2. Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis.
Innes KM; Szilvassy SJ; Davidson HE; Gibson L; Adams JM; Cory S
Exp Hematol; 1999 Jan; 27(1):75-87. PubMed ID: 9923446
[TBL] [Abstract][Full Text] [Related]
3. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.
Ogilvy S; Metcalf D; Gibson L; Bath ML; Harris AW; Adams JM
Blood; 1999 Sep; 94(6):1855-63. PubMed ID: 10477714
[TBL] [Abstract][Full Text] [Related]
4. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells.
Weber-Nordt RM; Henschler R; Schott E; Wehinger J; Behringer D; Mertelsmann R; Finke J
Blood; 1996 Oct; 88(7):2549-58. PubMed ID: 8839847
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
Lu L; Chaudhury P; Osmond DG
J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies.
Young HA; Klinman DM; Reynolds DA; Grzegorzewski KJ; Nii A; Ward JM; Winkler-Pickett RT; Ortaldo JR; Kenny JJ; Komschlies KL
Blood; 1997 Jan; 89(2):583-95. PubMed ID: 9002962
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of Bcl-2 on T and B cells in transgenic mice.
Katsumata M; Siegel RM; Louie DC; Miyashita T; Tsujimoto Y; Nowell PC; Greene MI; Reed JC
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11376-80. PubMed ID: 1454823
[TBL] [Abstract][Full Text] [Related]
9. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
Kim WI; Wiesner SM; Largaespada DA
Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage.
Zhou P; Qian L; Bieszczad CK; Noelle R; Binder M; Levy NB; Craig RW
Blood; 1998 Nov; 92(9):3226-39. PubMed ID: 9787159
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
[TBL] [Abstract][Full Text] [Related]
12. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.
Kikushige Y; Yoshimoto G; Miyamoto T; Iino T; Mori Y; Iwasaki H; Niiro H; Takenaka K; Nagafuji K; Harada M; Ishikawa F; Akashi K
J Immunol; 2008 Jun; 180(11):7358-67. PubMed ID: 18490735
[TBL] [Abstract][Full Text] [Related]
13. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice.
Nishijima I; Watanabe S; Nakahata T; Arai K
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551
[TBL] [Abstract][Full Text] [Related]
14. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
15. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
Wulf GM; Adra CN; Lim B
EMBO J; 1993 Dec; 12(13):5065-74. PubMed ID: 8262049
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
18. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation.
Domen J; Gandy KL; Weissman IL
Blood; 1998 Apr; 91(7):2272-82. PubMed ID: 9516125
[TBL] [Abstract][Full Text] [Related]
19. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.
Grillot DA; Merino R; Núñez G
J Exp Med; 1995 Dec; 182(6):1973-83. PubMed ID: 7500043
[TBL] [Abstract][Full Text] [Related]
20. B cell production and turnover in CBA/Ca, CBA/N and CBA/N-bcl-2 transgenic mice: xid-mediated failure among pre B cells is unaltered by bcl-2 overexpression.
Cancro MP; Sah AP; Levy SL; Allman DM; Constantinescu D; Schmidt MR; Woodland RT
Curr Top Microbiol Immunol; 2000; 252():31-8. PubMed ID: 11125490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
